Assessment of an LSDV-Vectored Vaccine for Heterologous Prime-Boost Immunizations against HIV.

Vaccines (Basel) · 2021 · PMC8620012 · PMID 34835214

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

showed a trendno p-value reported

NYVAC induced higher antibody responses to HIV Env and showed a trend towards eliciting higher cellular responses.

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.